In vivo studies performed by Li and colleagues revealed that anti-CD112R mAbs protected mice against subcutaneous MC38 tumors due to increased degranulation and IFN-γ production by tumor-infiltrating NK cells [20,131]. Here, IFNG is linked to neoplasm.